Simulations Plus, Inc.

NASDAQ:SLP

Medical - Healthcare Information Services

Healthcare
$18.50 +0.11%

+$0.02 today

Market cap
$374.16M
Beta
1.32
P/E (TTM)
-5.9
EPS (TTM)
-$3.12
52W Low $11.09High $21.01

Volume 0.00M

Average 0.35M

SLP Depreciation & Amortization

Non-cash asset write-downs added back to net income because no cash left the business.

Simulations Plus, Inc.NASDAQ: SLP

Depreciation & Amortization · Q2 FY2026 · quarter ended Feb 2026

Depreciation & amortization declines year over year

Q2 FY2026 depreciation & amortization of $1.45M fell 36.3% year over year, behind the -19.3% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 7.6% from the prior quarter. Over 3 fiscal years it compounded at +32.0% a year.

Context

  • Depreciation & amortization amounted to 10.4% of revenue in FY2025, up 2.3 pp from a year earlier.
  • Depreciation & amortization increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -36.3% toward the trailing-twelve-month pace of -19.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterFeb 2026
$1.45M+7.6% QoQ
Last fiscal yearAug 2025
$8.21M+44.9% YoY
LTMFeb 2026
$6.47M-19.3% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-36.3%——
1 year+44.9%——
3-year CAGR+32.0%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the cash flow

Latest · FY2025
8.21M USD
Year-over-year change
+44.9%
4-year CAGR
+23.0%

Depreciation & Amortization vs competitors

How SLP compares with its peers on the latest reported figures

  • Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -19.3% is the lowest of 11, against a peer median of +12.4%.
  • Depreciation & amortization amounts to 8.0% of revenue for SLP, versus a peer median of 23.3%.
SLP Competitors
Depreciation & Amortization for SLP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DHDefinitive Healthcare Corp.LTM Mar 2026$55.54M USD+5.2%-0.5%23.3%
AGLAgilon Health, Inc.LTM Mar 2026$28.51M USD+11.8%+27.6%0.5%
CLLSCellectis S.A.LTM Mar 2026$19.68M USD-2.6%+3.0%28.9%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$9.98M USD+13.0%+19.6%12.3%
NRCNational Research CorporationLTM Mar 2026$8.25M USD+34.9%+13.0%6.0%
SLPSimulations Plus, Inc.LTM Feb 2026$6.47M USD-19.3%+32.0%8.0%
OPRXOptimizeRx CorporationLTM Mar 2026$4.3M USD-1.4%+28.9%4.0%
KRROKorro Bio, Inc.LTM Mar 2026$3.75M USD-7.8%+14.7%97.6%
ACIUAC Immune S.A.LTM Dec 2025CHF 2.5M CHF+15.5%+0.4%69.9%
NAKANakamoto Inc.LTM Mar 2026$1.34M USD+611.6%+25.6%34.2%
ANROAlto Neuroscience, Inc.LTM Mar 2026$674K USD+14.4%+24.6%—
Peer median (excluding SLP) —+12.4%+17.2%23.3%

Competitors are the stored peer set for SLP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Aug 2023
FY2024
Aug 2024
FY2025
Aug 2025
Net Income9.78M12.48M9.96M9.95M(64.72M)
Depreciation & Amortization3.59M3.57M3.84M5.67M8.21M
Deferred Income Tax(628K)(270K)(2.1M)(1.77M)(5.43M)
Stock-Based Compensation2.75M3.04M4.83M6.54M6.35M
Change in Working Capital974K(2.62M)5.1M(4.21M)(2.59M)
Accounts Receivables(2.43M)(3.94M)4.1M3.13M(581K)
Inventory3.15M0000
Accounts Payables39K(162K)(81K)(477K)(132K)
Other Working Capital210K1.48M1.09M(6.86M)(1.87M)
Other Non-Cash Items2.74M1.7M219K(2.86M)76.29M
Operating Cash Flow19.2M17.9M21.86M13.32M18.13M
Capital Expenditures(4.58M)(3.97M)(4.27M)(566K)(713K)
Acquisitions (Net)2.95M3.15M(8.22M)(98.77M)0
Purchases of Investments(122.4M)(100.85M)(95.05M)(67.16M)(6.5M)
Sales of Investments100.23M109.12M114.91M116.27M15.01M
Other Investing Activities(2.95M)(3.15M)(3.82M)(3.74M)(4.24M)
Investing Cash Flow(26.74M)4.31M7.37M(53.97M)3.56M
Debt Repayment00000
Common Stock Issued1.46M891K0731K430K
Common Stock Repurchased00(20M)00
Dividends Paid(4.81M)(4.85M)(4.81M)(4.8M)0
Other Financing Activities(1.33M)(3.67M)1.54M(2.5M)(1.58M)
Financing Cash Flow(4.68M)(7.62M)(23.27M)(6.57M)(1.15M)
Effect of Forex Changes00000
Net Change in Cash(12.22M)14.58M5.96M(47.21M)20.54M
Free Cash Flow14.63M13.93M17.58M12.75M17.41M

Simulations Plus, Inc.

NASDAQ:SLP

Intrinsic Alpha fair value

Locked

Current Price

$18.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.